drugset / Trial / NCT03764462
Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics of AD-101 in healthy volunteers
Timeline
- Start
- 2018-12-14
- Primary completion
- 2019-01-02
- Completion
- 2019-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISMIDENON | Small molecule | 45 mg | Oral |
| Subject | Raloxifene | Other / unclassified | 60 mg | Oral |